Cited by 203Cannabis and Cannabinoid ResearchSchizophrenia research and treatmentPsychedelics and Drug Studies

The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.

Induction of Psychosis byΔ9-Tetrahydrocannabinol Reflects Modulation of Prefrontal and Striatal Function During Attentional Salience Processing

Bhattacharyya, Sagnik·2012·Archives of General Psychiatry

DOI 10.1001/archgenpsychiatry.2011.161

Open this paper in CoChat — free account

Abstract

CONTEXT: The aberrant processing of salience is thought to be a fundamental factor underlying psychosis. Cannabis can induce acute psychotic symptoms, and its chronic use may increase the risk of schizophrenia. We investigated whether its psychotic effects are mediated through an influence on attentional salience processing. OBJECTIVE: To examine the effects of Δ9-tetrahydrocannabinol (Δ9-THC) and cannabidiol (CBD) on regional brain function during salience processing. DESIGN: Volunteers were studied using event-related functional magnetic resonance imaging on 3 occasions after administration of Δ9-THC, CBD, or placebo while performing a visual oddball detection paradigm that involved allocation of attention to infrequent (oddball) stimuli within a string of frequent (standard) stimuli. SETTING: University center. PARTICIPANTS: Fifteen healthy men with minimal previous cannabis use. MAIN OUTCOME MEASURES: Symptom ratings, task performance, and regional brain activation. RESULTS: During the processing of oddball stimuli, relative to placebo, Δ9-THC attenuated activation in the right caudate but augmented it in the right prefrontal cortex. Δ9-Tetrahydrocannabinol also reduced the response latency to standard relative to oddball stimuli. The effect of Δ9-THC in the right caudate was negatively correlated with the severity of the psychotic symptoms it induced and its effect on response latency. The effects of CBD on task-related activation were in the opposite direction of those of Δ9-THC; relative to placebo, CBD augmented left caudate and hippocampal activation but attenuated right prefrontal activation. CONCLUSIONS: Δ9-Tetrahydrocannabinol and CBD differentially modulate prefrontal, striatal, and hippocampal function during attentional salience processing. These effects may contribute to the effects of cannabis on psychotic symptoms and on the risk of psychotic disorders.

Integrity signals

Registry

Crossref · 10.1001/archgenpsychiatry.2011.161

Cites

73 of 73 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The Positive and Negative Syndrome Scale (PANSS) for schizophrenia.
Kay, S. R., Fiszbein, A., & Opler, L. A. (1987) · Schizophrenia Bulletin · doi:10.1093/schbul/13.2.261 · Cited by 21,378
Co-Planar Stereotaxic Atlas of the Human Brain
Talairach, J., & Tournoux, P. (1988) · Medical Entomology and Zoology · Cited by 11,798
Dissociable intrinsic connectivity networks for salience processing and executive control
Seeley, W. W., Menon, V., Schatzberg, A. F., Keller, J., Glover, G. H., Kenna, H., Reiss, A. L., & Greicius, M. D. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.5587-06.2007 · Cited by 7,426
Psychosis as a state of aberrant salience: a framework linking biology, phenomenology and pharmacology in schizophrenia
Kapur, S. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.1.13 · Cited by 2,813
The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway
Howes, O. D., & Kapur, S. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp006 · Cited by 2,693
The debate over dopamine’s role in reward: the case for incentive salience
Berridge, K. C. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0578-x · Cited by 2,347
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review.
Moore, T. H., Zammit, S., Lingford-Hughes, A., Barnes, T. R., Jones, P. B., Burke, M., & Lewis, G. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61162-3 · Cited by 2,224
The diverse CB 1 and CB 2 receptor pharmacology of three plant cannabinoids: Δ 9 ‐tetrahydrocannabinol, cannabidiol and Δ 9 ‐tetrahydrocannabivarin
Pertwee, R. G. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707442 · Cited by 2,047
The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: Implications for psychosis
D'Souza, D. C., Perry, E., MacDougall, L., Ammerman, Y., Cooper, T., Wu, Y.-T., Braley, G., Gueorguieva, R., & Krystal, J. H. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300496 · Cited by 1,024
Endogenous Potentials Generated in the Human Hippocampal Formation and Amygdala by Infrequent Events
Halgren, E., Squires, N. K., Wilson, C. L., Rohrbaugh, J., Babb, T. L., & Crandall, P. H. (1980) · Science · doi:10.1126/science.7434000 · Cited by 778
Adverse effects of cannabis
Hall, W., & Solowij, N. (1998) · The Lancet · doi:10.1016/s0140-6736(98)05021-1 · Cited by 778
Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology
Bhattacharyya, S., Morrison, P. D., Fusar-Poli, P., Martin-Santos, R., Borgwardt, S., Winton-Brown, T., Nosarti, C., O' Carroll, C. M., Seal, M., Allen, P., et al. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.184 · Cited by 680
Self-citation
Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction
D’Souza, D. C., Abi-Saab, W. M., Madonick, S., Forselius-Bielen, K., Doersch, A., Braley, G., Gueorguieva, R., Cooper, T. B., & Krystal, J. H. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.12.006 · Cited by 617
Action of cannabidiol on the anxiety and other effects produced by ?9-THC in normal subjects
Zuardi, A. W., Shirakawa, I., Finkelfarb, E., & Karniol, I. G. (1982) · Psychopharmacology · doi:10.1007/bf00432554 · Cited by 608
Dose related risk of motor vehicle crashes after cannabis use
Ramaekers, J. G., Berghaus, G., van Laar, M., & Drummer, O. H. (2003) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2003.10.008 · Cited by 573
A cortical network sensitive to stimulus salience in a neutral behavioral context across multiple sensory modalities.
Downar, J., Crawley, A. P., Mikulis, D. J., & Davis, K. D. (2002) · Journal of Neurophysiology · doi:10.1152/jn.00636.2001 · Cited by 544
Substantia nigra/ventral tegmental reward prediction error disruption in psychosis
Murray, G. K., Corlett, P. R., Clark, L., Pessiglione, M., Blackwell, A. D., Honey, G., Jones, P. B., Bullmore, E. T., Robbins, T. W., & Fletcher, P. C. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002058 · Cited by 532
From dopamine to salience to psychosis—Linking biology, pharmacology and phenomenology of psychosis
Kapur, S., Mizrahi, R., & Li, M. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.01.003 · Cited by 512
Absolute Coding of Stimulus Novelty in the Human Substantia Nigra/VTA
Bunzeck, N., & Düzel, E. (2006) · Neuron · doi:10.1016/j.neuron.2006.06.021 · Cited by 503
Generic brain activation mapping in functional magnetic resonance imaging: A nonparametric approach
Brammer, M. J., Bullmore, E. T., Simmons, A., Williams, S., Grasby, P. M., Howard, R. J., Woodruff, P. W. R., & Rabe‐Hesketh, S. (1997) · Magnetic Resonance Imaging · doi:10.1016/s0730-725x(97)00135-5 · Cited by 470
Distinct Effects of Δ9-Tetrahydrocannabinol and Cannabidiol on Neural Activation During Emotional Processing
Fusar-Poli, P., Crippa, J. A., Bhattacharyya, S., Borgwardt, S. J., Allen, P., Martin-Santos, R., Seal, M., Surguladze, S. A., O’Carrol, C., Atakan, Z., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2008.519 · Cited by 465
Self-citation
Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action
Zuardi, A. W. (2008) · Revista Brasileira de Psiquiatria · doi:10.1590/s1516-44462008000300015 · Cited by 421
Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug
Zuardi, A. W., Crippa, J. A. S., Hallak, J. E. C., Moreira, F. A., & Guimarães, F. S. (2006) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2006000400001 · Cited by 415
Shifting and stopping: fronto-striatal substrates, neurochemical modulation and clinical implications
Robbins, T. W. (2007) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2007.2097 · Cited by 413
Being stoned: a review of self‐reported cannabis effects
Green, B., Kavanagh, D. J., & Young, R. M. (2003) · Drug and Alcohol Review · doi:10.1080/09595230310001613976 · Cited by 390
Cognitive and subjective dose-response effects of acute oral Δ 9 -tetrahydrocannabinol (THC) in infrequent cannabis users
Curran, V. H., Brignell, C. M., Fletcher, S., Middleton, P. M., & Henry, J. A. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1169-0 · Cited by 370
Neurobiology of Dopamine in Schizophrenia
Guillin, O., Abi‐Dargham, A., & Laruelle, M. (2007) · International Review of Neurobiology · doi:10.1016/s0074-7742(06)78001-1 · Cited by 365
Dysfunction of ventral striatal reward prediction in schizophrenic patients treated with typical, not atypical, neuroleptics
Juckel, G., Schlagenhauf, F., Koslowski, M., Filonov, D., Wüstenberg, T., Villringer, A., Knutson, B., Kienast, T., Gallinat, J., Wrase, J., et al. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0405-4 · Cited by 323
Human striatal response to salient nonrewarding stimuli
Zink, C. F., Pagnoni, G., Martin, M. E., Dhamala, M., & Berns, G. S. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-22-08092.2003 · Cited by 312
Effects of cannabidiol (CBD) on regional cerebral blood flow
Crippa, J. A. D. S., Zuardi, A. W., Garrido, G. E. J., Wichert-Ana, L., Guarnieri, R., Ferrari, L., Azevedo-Marques, P. M., Hallak, J. E. C., McGuire, P. K., & Busatto, G. F. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300340 · Cited by 307
Cannabidiol interferes with the effects of Δ9-tetrahydrocannabinol in man
Karniol, I. G., Shirakawa, I., Kasinski, N., Pfeferman, A., & Carlini, E. A. (1974) · European Journal of Pharmacology · doi:10.1016/0014-2999(74)90129-0 · Cited by 303
Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis
Morgan, C. J. A., & Curran, H. V. (2008) · British Journal of Psychiatry · doi:10.1192/bjp.bp.107.046649 · Cited by 300
Effects of Acute Smoked Marijuana on Complex Cognitive Performance
Hart, C. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00273-1 · Cited by 272
Δ9-Tetrahydrocannabinol Induces Dopamine Release in the Human Striatum
Bossong, M., van Berckel, B. N., Boellaard, R., Zuurman, L., Schuit, R., Windhorst, A., van Gerven, J. V., Ramsey, N., Lammertsma, A., & Kahn, R. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.138 · Cited by 262
Do patients with schizophrenia exhibit aberrant salience?
Roiser, J. P., Stephan, K. E., den Ouden, H. E. M., Barnes, T. R. E., Friston, K. J., & Joyce, E. M. (2009) · Psychological Medicine · doi:10.1017/s0033291708003863 · Cited by 262
Marijuana Intoxication : Common Experiences
TART, C. T. (1970) · Nature · doi:10.1038/226701a0 · Cited by 252
Modulation of Mediotemporal and Ventrostriatal Function in Humans by Δ9-Tetrahydrocannabinol
Bhattacharyya, S., Fusar‐Poli, P., Borgwardt, S., Martín‐Santos, R., Nosarti, C., O’Carroll, C., Allen, P., Seal, M. L., Fletcher, P. C., Crippa, J. A. S., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.17 · Cited by 246
Self-citation
The formation of abnormal associations in schizophrenia: Neural and behavioral evidence
Jensen, J., Willeit, M., Zipursky, R. B., Savina, I., Smith, A. J., Menon, M., Crawley, A. P., & Kapur, S. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301437 · Cited by 225
An event-related functional magnetic resonance imaging study of an auditory oddball task in schizophrenia
Kiehl, K. A., & Liddle, P. F. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(00)00117-1 · Cited by 214
Comparison of the subjective effects of Δ 9 -tetrahydrocannabinol and marijuana in humans
Wachtel, S. R., ElSohly, M. A., Ross, S. A., AMBRE, J. J., & de Wit, H. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1033-2 · Cited by 210
Cannabidiol, a Nonpsychotropic Component of Cannabis, Inhibits Cue-Induced Heroin Seeking and Normalizes Discrete Mesolimbic Neuronal Disturbances
Ren, Y., Whittard, J., Higuera-Matas, A., Morris, C. V., & Hurd, Y. L. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.4291-09.2009 · Cited by 210
Human Hippocampal and Parahippocampal Activity during Visual Associative Recognition Memory for Spatial and Nonspatial Stimulus Configurations
Düzel, E., Habib, R., Rotte, M., Guderian, S., Tulving, E., & Heinze, H. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-28-09439.2003 · Cited by 205
Cannabidiol Attenuates the Appetitive Effects of Δ9-Tetrahydrocannabinol in Humans Smoking Their Chosen Cannabis
Morgan, C. J., Freeman, T. P., Schafer, G. L., & Curran, H. V. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.58 · Cited by 196
Marijuana use is associated with a reorganized visual-attention network and cerebellar hypoactivation
Chang, L., Yakupov, R., Cloak, C. C., & Ernst, T. (2006) · Brain · doi:10.1093/brain/awl064 · Cited by 189
Cannabinoids potentiate emotional learning plasticity in neurons of the medial prefrontal cortex through basolateral amygdala inputs
Laviolette, S. R., & Grace, A. A. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.0707-06.2006 · Cited by 189
Frontal Responses During Learning Predict Vulnerability to the Psychotogenic Effects of Ketamine: Linking Cognition, Brain Activity, and Psychosis
Corlett, P. R., Honey, G. D., Aitken, M. R. F., Dickinson, A., Shanks, D. R., Absalom, A. R., Lee, M., Pomarol-Clotet, E., Murray, G. K., McKenna, P. J., et al. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.6.611 · Cited by 182
Effects of Smoking Marijuana on Brain Perfusion and Cognition
OʼLeary, D. S. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00425-0 · Cited by 173
Human striatal activation reflects degree of stimulus saliency
Zink, C. F., Pagnoni, G., Chappelow, J., Martin-Skurski, M. E., & Berns, G. S. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2005.08.006 · Cited by 169
Temporal Lobe Dysfunction in Medication-Naïve Boys With Attention-Deficit/Hyperactivity Disorder During Attention Allocation and Its Relation to Response Variability
Rubia, K., Smith, A. B., Brammer, M. J., & Taylor, E. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.02.024 · Cited by 168
Interhemispheric Integration: II. Symmetry and Convergence of the Corticostriatal Projections of the Left and the Right Principal Sulcus (PS) and the Left and the Right Supplementary Motor Area (SMA) of the Rhesus Monkey
McGuire, P. K., Bates, J. F., & Goldman, P. S. (1991) · Cerebral Cortex · doi:10.1093/cercor/1.5.408 · Cited by 161
Effects of age and sex on developmental neural networks of visual–spatial attention allocation
Rubia, K., Hyde, Z., Halari, R., Giampietro, V., & Smith, A. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.02.058 · Cited by 148
Effects of long-term cannabis use on selective attention: An event-related potential study
Solowij, N., Michie, P. T., & Fox, A. M. (1991) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(91)90382-c · Cited by 124
Influence of cannabidiol on delta‐9‐tetrahydrocannabinol effects
Dalton, W. S., Martz, R. C., Lemberger, L., Rodda, B. E., & Forney, R. B. (1976) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1976193300 · Cited by 123
Cocaine Decreases Cortical Cerebral Blood Flow but Does Not Obscure Regional Activation in Functional Magnetic Resonance Imaging in Human Subjects
Gollub, R. L., Breiter, H. C., Kantor, H. L., Kennedy, D. N., Gastfriend, D. R., Mathew, R. T., Makris, N., Guimarães, A. R., Riorden, J., Campbell, T., et al. (1998) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199807000-00003 · Cited by 120
Adaptive anterior hippocampal responses to oddball stimuli
Strange, B. A., & Dolan, R. J. (2001) · Hippocampus · doi:10.1002/hipo.1084 · Cited by 117
Cannabinoid Agonists but not Inhibitors of Endogenous Cannabinoid Transport or Metabolism Enhance the Reinforcing Efficacy of Heroin in Rats
Solinas, M., Panlilio, L. V., Tanda, G., Makriyannis, A., Matthews, S. A., & Goldberg, S. R. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300754 · Cited by 103
Cannabidiol reverses the reduction in social interaction produced by low dose Δ9-tetrahydrocannabinol in rats
Malone, D. T., Jongejan, D., & TAYLOR, D. A. H. B. (2009) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2009.04.010 · Cited by 91
Effects of acute oral Δ9-tetrahydrocannabinol and standardized cannabis extract on the auditory P300 event-related potential in healthy volunteers
Roser, P., Juckel, G., Rentzsch, J., Nadulski, T., Gallinat, J., & Stadelmann, A. M. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2008.04.008 · Cited by 88
Coupling of regional activations in a human brain during an object and face affect recognition task
Ioannides, A. A., Liu, L. C., Kwapień, J., Drożdż, S., & Streit, M. (2000) · Human Brain Mapping · doi:10.1002/1097-0193(200010)11:2 · Cited by 85
Exposure to Δ-9-Tetrahydrocannabinol (THC) Increases Subsequent Heroin Taking but not Heroin's Reinforcing Efficacy: A Self-Administration Study in Rats
Solinas, M., Panlilio, L. V., & Goldberg, S. R. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300431 · Cited by 85
Disruption of Frontal Theta Coherence by Δ9-Tetrahydrocannabinol is Associated with Positive Psychotic Symptoms
Morrison, P. D., Nottage, J. F., Stone, J. M., Bhattacharyya, S., Tunstall, N., Brenneisen, R., Holt, D., Wilson, D., Sumich, A. L., McGuire, P. K., et al. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.222 · Cited by 83
Self-citation
Significant decreases in frontal and temporal [11C]-raclopride binding after THC challenge
Stokes, P. R. A., Egerton, A., Watson, B., Reid, A., Breen, G., Lingford-Hughes, A., Nutt, D., & Mehta, M. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.04.274 · Cited by 75
Influence of marijuana on driving
Robbe, H. W. J. (1994) · doi:10.26481/dis.19940526hr · Cited by 74
Acute marijuana effects on rCBF and cognition
OʼLeary, D. S., Block, R. I., Flaum, M., Schultz, S. K., Ponto, L. L. B., Watkins, G. L., Hurtig, R. R., Andreasen, N. C., & Hichwa, R. D. (2000) · Neuroreport · doi:10.1097/00001756-200011270-00047 · Cited by 64
Characterization of effects of mean arterial blood pressure induced by cocaine and cocaine methiodide on BOLD signals in rat brain
Luo, F. R., Wu, G., Li, Z., & Li, S. (2003) · Magnetic Resonance in Medicine · doi:10.1002/mrm.10366 · Cited by 63
THE INFLUENCE OF CANNABIS ON DRIVING
Sexton, B. F., Tunbridge, R. J., Brook-Carter, N., Jackson, P. G., Wright, K. A., Stark, M. M., & Englehart, K. (2000) · OpenGrey (Institut de l'Information Scientifique et Technique) · Cited by 51
Dose‐dependent effects of Δ9‐tetrahydrocannabinol on rates of local cerebral glucose utilization in rat
Freedland, C. S., Whitlow, C. T., Miller, M. D., & Porrino, L. J. (2002) · Synapse · doi:10.1002/syn.10089 · Cited by 48
Hippocampal involvement in detection of deviant auditory and visual stimuli
Crottaz‐Herbette, S., Lau, K. M., Glover, G. H., & Menon, V. (2004) · Hippocampus · doi:10.1002/hipo.20039 · Cited by 39
Effect of Acute Marijuana on Cardiovascular Function and Central Nervous System Pharmacokinetics of [15O]Water: Effect in Occasional and Chronic Users
Ponto, L. L. B., OʼLeary, D. S., Koeppel, J. A., Block, R. I., Watkins, G. L., Richmond, J. C. W., Ward, C. A., Clermont, D., Schmitt, B., & Hichwa, R. D. (2004) · The Journal of Clinical Pharmacology · doi:10.1177/0091270004265699 · Cited by 31
A Validation of Event-Related fMRI Comparisons Between Users of Cocaine, Nicotine, or Cannabis and Control Subjects
Murphy, K., Dixon, V., LaGrave, K., Kaufman, J. N., Risinger, R. C., Bloom, A. S., & Garavan, H. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.7.1245 · Cited by 29
The Cannabis Experience: An Interpretative Study of the Effects of Marijuana and Hashish
Joseph, J., Berke, C. C. H., & Berke, J. H. (1974) · Cited by 8
ABERRANT SALIENCE IN SUBJECTS AT HIGH RISK OF PSYCHOSIS RELATED TO ALTERED DORSOLATERAL PREFRONTAL FUNCTION
Roiser, J. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.02.191 · Cited by 2
Untitled work
Liddle (2001) · doi:10.1002/1097-0193(200102)12:2

Sorted by citations

Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders
Campos, A. C., Moreira, F. A., Gomes, F. V., Del Bel, E. A., & Guimarães, F. S. (2012) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2011.0389 · Cited by 475
Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment
Englund, A., Morrison, P. D., Nottage, J. F., Hague, D., Kane, F., Bonaccorso, S., Stone, J. M., Reichenberg, A., Brenneisen, R., Holt, D., et al. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112460109 · Cited by 479
Structural and Functional Imaging Studies in Chronic Cannabis Users: A Systematic Review of Adolescent and Adult Findings
Batalla, A., Bhattacharyya, S., Yücel, M., Fusar‐Poli, P., Crippa, J. A. S., Nogué, S., Torrens, M., Pujol, J., Farré, M., & Martín‐Santos, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055821 · Cited by 437
Self-citation
Cannabidiol for the Reduction of Cue-Induced Craving and Anxiety in Drug-Abstinent Individuals With Heroin Use Disorder: A Double-Blind Randomized Placebo-Controlled Trial
Hurd, Y. L., Spriggs, S. A., Alishayev, J., Winkel, G. H., Gurgov, K., Kudrich, C., Oprescu, A. M., & Salsitz, E. A. (2019) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2019.18101191 · Cited by 344
Antipsychotic Treatment and Functional Connectivity of the Striatum in First-Episode Schizophrenia
Sarpal, D. K., Robinson, D. G., Lencz, T., Árgyelán, M., Ikuta, T., Karlsgodt, K. H., Gallego, J. A., Kane, J. M., Szeszko, P. R., & Malhotra, A. K. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1734 · Cited by 328

See all 203

Authors: Bhattacharyya, S.
Affiliations: King's College London (GB)
Corresponding author: Bhattacharyya, Sagnik
ORCID: Bhattacharyya, Sagnik
Venue: Archives of General Psychiatry
Publisher: American Medical Association (AMA)
Published: 2012-01-01
Volume: 69
Issue: 1
Pages: 27
ISSN: 0003-990X (ISSN-L)
DOI: 10.1001/archgenpsychiatry.2011.161
OpenAlex: W2158902140
Cited by: 203
References: 73
Citations by year: 2026: 5 · 2025: 5 · 2024: 12 · 2023: 7 · 2022: 8 · 2021: 19 · 2020: 18 · 2019: 18 · 2018: 16 · 2017: 20 · 2016: 11 · 2015: 10 · 2014: 20 · 2013: 20 · 2012: 14
FWCI: 15.05
Type: journal article
Language: en
Open access: closed
Locations: Archives of General Psychiatry (publishedVersion)
PubMed (publishedVersion)
Research Portal (King's College London) (submittedVersion)
Funders: National Institute for Health and Care Research (NIHR-CS-011-001)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
Keywords: delta-9-tetrahydrocannabinol, cannabidiol, cannabis-induced psychosis, caudate nucleus, prefrontal cortex, hippocampus, striatal function, psychotic symptoms, schizophrenia risk, response latency
MeSH terms: Adult, Attention, Cannabidiol, Corpus Striatum, Hallucinogens, Humans, Male, Psychotic Disorders, Reaction Time, Space Perception, Dronabinol, Prefrontal Cortex, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Induction of Psychosis byΔ9-Tetrahydrocannabinol Reflects Modulation of Prefrontal and Striatal Function During Attentional Salience Processing

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks